Novartis Has Blockbuster Drugs Coming: Rundquist

April 24 (Bloomberg) -- Odile Rundquist, senior pharmaceutical analyst at Helvea, talks with Manus Cranny about first-quarter results at Novartis AG and examines the overall pharmaceutical market. She speaks on Bloomberg Television's "On The Move."
Should the U.S. Have Already Raised Rates?
35:55 - UBS Global Economist Paul Donovan discusses the impact of emerging markets on the U.S. and Europe, the U.S. jobs report and inflation inequality. He speaks to Bloomberg's Guy Johnson and Anna Edwards on "Countdown." (Source: Bloomberg)
  • Did Draghi Show His Dovish Credentials?
  • Behind the Wheel of Croatia's 1,000HP Electric Supercar
  • What You Need to Know: G20 Summit, ECB, US Jobs